Stay updated on Dolatav Clinical Trial: Nucleoside Sparing in HIV-1

Sign up to get notified when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.
Latest website image capture
Clouds background image

Latest updates to the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed and Revision: v3.3.3 has been removed. This appears to be a minor version label update rather than substantive content.
    Difference
    0.1%
    Check dated 2026-01-14T01:57:01.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Footer now displays 'Revision: v3.3.3'. The HHS Vulnerability Disclosure link and the previous 'Revision: v3.3.2' entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T22:29:25.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The Publications section now includes a note stating that publications are provided voluntarily by the person entering information and pertain to the study results. The revision tag was updated to v3.3.2, replacing v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:35:09.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page no longer displays the government funding status notice related to NIH operations; the core study details and sections remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:52:27.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The new screenshot shows only layout and styling adjustments with no changes to the study's title, objectives, eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:56:27.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T05:20:03.000Z thumbnail image

Stay in the know with updates to Dolatav Clinical Trial: Nucleoside Sparing in HIV-1

Enter your email address, and we'll notify you when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.